Education
About Us
Working with TipRanks
Follow Us
Capstone Therapeutics Corp (CAPS)
NASDAQ:CAPS
RESEARCH TOOLSreports
CAPS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$1.65 - $16.18
Previous CloseN/A
Volume2.10K
Average Volume (3M)691.53K
Market Cap
$12.55M
Enterprise Value$46.60M
Total Cash (Recent Filing)$5.45M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta0.42
Next Earnings
May 09, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-34.86
Shares Outstanding5,190,251
10 Day Avg. Volume114,179
30 Day Avg. Volume691,532
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.14
Price to Cash Flow (P/CF)0.90
P/FCF Ratio0.50
Enterprise Value/Market Cap3.71
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit4.85
Enterprise Value/Ebitda-27.22
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Capstone Therapeutics News
PremiumCompany Announcements
Capstone Holding Corp. Expands Toro Stone Brand Nationwide
PremiumCompany Announcements
Capstone Therapeutics Announces Follow-On Public Offering---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
CAPS FAQ
What was Capstone Therapeutics Corp’s price range in the past 12 months?
Capstone Therapeutics Corp lowest stock price was $1.65 and its highest was $16.18 in the past 12 months.
What is Capstone Therapeutics Corp’s market cap?
Capstone Therapeutics Corp’s market cap is $12.55M.
When is Capstone Therapeutics Corp’s upcoming earnings report date?
Capstone Therapeutics Corp’s upcoming earnings report date is May 09, 2025 which is in 26 days.
How were Capstone Therapeutics Corp’s earnings last quarter?
Capstone Therapeutics Corp released its earnings results on Apr 01, 2025. The company reported -$7.2 earnings per share for the quarter, missing the consensus estimate of -$1.1 by -$6.1.
Is Capstone Therapeutics Corp overvalued?
According to Wall Street analysts Capstone Therapeutics Corp’s price is currently Overvalued.
Does Capstone Therapeutics Corp pay dividends?
Capstone Therapeutics Corp does not currently pay dividends.
What is Capstone Therapeutics Corp’s EPS estimate?
Capstone Therapeutics Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Capstone Therapeutics Corp have?
Capstone Therapeutics Corp has 5,190,251 shares outstanding.
What happened to Capstone Therapeutics Corp’s price movement after its last earnings report?
Capstone Therapeutics Corp reported an EPS of -$7.2 in its last earnings report, missing expectations of -$1.1. Following the earnings report the stock price went down -2.905%.
Which hedge fund is a major shareholder of Capstone Therapeutics Corp?
Currently, no hedge funds are holding shares in CAPS
---
Company Description
Capstone Therapeutics Corp
Capstone Therapeutics Corp., a biotechnology company, develops novel peptides and other molecules for helping patients with under-served medical conditions in the United States. It develops Apo E mimetic peptide molecule AEM-28 and its analogs that have completed Phase Ia and Phase Ib/IIa clinical trials for lipoprotein metabolism. The company was formerly known as OrthoLogic Corp. and changed its name to Capstone Therapeutics Corp. in May 2010. Capstone Therapeutics Corp. was founded in 1987 and is headquartered in Tempe, Arizona.
---
Technical Analysis
---